NCT07202065View on ClinicalTrials.gov

Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Dosing Immunoglobulin (Dose Ig)

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

900

Participants

Timeline

Start Date

April 28, 2025

Primary Completion Date

March 31, 2027

Study Completion Date

March 31, 2027

Conditions
MyelomaNon Hodgkin's LymphomaLeukemia
Interventions
BIOLOGICAL

Immune Globulin Intravenous

Participants will be treated with intravenous immunoglobulin monthly (every 4 weeks ± 1 week).

Trial Locations (3)

3004

RECRUITING

Austin Hospital, Melbourne

RECRUITING

Northern Health, Melbourne

5000

RECRUITING

Royal Adelaide Hospital, Adelaide

All Listed Sponsors
lead

Monash University

OTHER